These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30219077)

  • 1. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
    Sun L; Feng L; Cui J
    Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2/Stat3 signaling.
    Liu H; Wang M; Liang N; Guan L
    Turk J Gastroenterol; 2019 Aug; 30(8):722-731. PubMed ID: 31418417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
    Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
    Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
    Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
    J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.
    Yao RR; Li JH; Zhang R; Chen RX; Wang YH
    World J Surg Oncol; 2018 Jan; 16(1):9. PubMed ID: 29338742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of claudin-12 promotes the metastatic phenotype of human bronchial epithelial cells and is associated with poor prognosis in lung squamous cell carcinoma.
    Sun L; Feng L; Cui J
    Exp Ther Med; 2019 Jan; 17(1):165-174. PubMed ID: 30651778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Lu P; Ding Q; Li X; Ji X; Li L; Fan Y; Xia Y; Tian D; Liu M
    EBioMedicine; 2019 Oct; 48():100-116. PubMed ID: 31597595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
    Gong QZ; Xiao D; Gong GY; Xu J; Wen XD; Feng F; Qu W
    Curr Cancer Drug Targets; 2019; 19(7):583-593. PubMed ID: 30585547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight junction protein CLDN17 serves as a tumor suppressor to reduce the invasion and migration of oral cancer cells by inhibiting epithelial-mesenchymal transition.
    Xu YN; Deng MS; Liu YF; Yao J; Xiao ZY
    Arch Oral Biol; 2022 Jan; 133():105301. PubMed ID: 34781072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression.
    Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
    Tang C; Feng W; Bao Y; Du H
    Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin/STAT3 pathway in hepatocellular carcinoma.
    Wang G; Zhou H; Gu Z; Gao Q; Shen G
    Oncol Rep; 2018 Aug; 40(2):979-987. PubMed ID: 29901157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
    Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J
    Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of intratumour inflammatory cytokine mRNA levels of hepatocellular carcinoma patients and activation of two distinct pathways govern IL-8 induced epithelial-mesenchymal transition in human hepatic cancer cell lines.
    Peng S; Chen Y; Gong Y; Li Z; Xie R; Lin Y; Zou B; Li J; Zeng L
    Cytokine; 2019 Jul; 119():81-89. PubMed ID: 30903867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ; Sui MH; Sun ZX; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleostemin promotes hepatocellular carcinoma by regulating the function of STAT3.
    Zhang X; Lv J; Luo H; Liu Z; Xu C; Zhou D; Tang L; Zhang Z; Liu J; Xiao M; Yao Y; Qu L; Lu C
    Exp Cell Res; 2020 Feb; 387(1):111748. PubMed ID: 31785228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.